ROBIN HOWARD W

PrivateCIK: 1206869
Location

SAN FRANCISCO, CA

Senior insider sale

President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction

$829.2K

21.57K shares

What this filing means

ROBIN HOWARD W plans to sell 21.57K shares of NEKTAR THERAPEUTICS valued at approximately $829.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderROBIN HOWARD WCIK 1206869
IssuerNEKTAR THERAPEUTICSCIK 906709
DirectorOfficer· President & CEO
Since Aug 2018
21.57K
Shares to sell
$829.2K
Approx. market value
6.67K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months9
Sort

Restricted Stock Vesting

Compensation

11/15/2021
950.00

Restricted Stock Vesting

Compensation

8/15/2021
728.00

Restricted Stock Vesting

Compensation

11/15/2020
777.00

Restricted Stock Vesting

Compensation

8/23/2019
2K

Restricted Stock Vesting

Compensation

8/15/2019
436.00

Restricted Stock Vesting

Compensation

2/15/2017
480.00

Restricted Stock Vesting

Compensation

11/15/2016
353.00

Restricted Stock Vesting

Compensation

8/15/2016
712.00

Restricted Stock Vesting

Compensation

5/15/2016
230.00
Total acquired6.67K
Planned & Completed Dispositions5
Sort

Completed

Completed

Units to sell

6.67K

Market value

$256.8K

9/5/2025
Completed

Units to sell

5.17K

Market value

$174.1K

9/4/2025
Completed

Units to sell

1.50K

Market value

$45.2K

9/2/2025
Completed

Units to sell

1.57K

Market value

$41.8K

8/19/2025

Planned — Approximate Date

NASDAQPlanned

Units to sell

6.67K

Market value

$311.2K

9/9/2025
Total

Units

21.57K

Value

$829.2K